Status:
COMPLETED
Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The eye has long been recognized as a window to pathological processes occurring in the brain. By imaging the vascular system of the retina scientific understanding and clinical practice have been imp...
Eligibility Criteria
Inclusion
- For the patients with stroke: Inpatients with confirmed stroke (clinical and imaging) for less than 10 days
- For the controls: Individuals presenting at the Rothschild Foundation Hospital with no history of stroke who are matched to cases already included in the matching criteria: Age ± 5 years, Gender, high blood pressure (no history, untreated, treated) Diabetes (Yes, No), Body Mass Index (BMI \< 25, 25 ≥ BMI \< 30, BMI ≥ 30)
Exclusion
- Pregnant or breastfeeding woman
- Insufficient state of consciousness or physical condition to perform the adaptive optics examination
- For the patients with stroke: Hemorrhagic post-traumatic hematoma stroke type, or symptomatic stroke of a brain tumour or an arteriovenous malformation.
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2025
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04712747
Start Date
January 25 2021
End Date
January 14 2025
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Fondation A. de Rothschuld
Paris, France, 75019